Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine

Endokrynol Pol. 2023;74(6). doi: 10.5603/ep.98169.

Authors

Tomasz Krzysztof Bryś¹, Violetta Rosiek², Beata Rembielak-Stawecka³, Marek Rajca³, Marek Kudła³

Affiliations

¹ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland. brystomasz@wp.pl.
² Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
³ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland.

PMID: 38159206
DOI: 10.5603/ep.98169

Abstract

No required for Clinical Vignette.

Keywords: carcinoid syndrome; ovarian metastatic NET; peptide receptor radionuclide therapy; somatostatin analogue.

MeSH terms

Female
Humans
Intestine, Small
Neuroendocrine Tumors*
Ovarian Neoplasms*
Somatostatin

Substances

Somatostatin